Reduced cardiotoxicity and increased cytotoxicity in a novel anthracycline analogue, 4'-amino-3'-hydroxy-doxorubicin.

MLA

Danesi, R., et al. “Reduced Cardiotoxicity and Increased Cytotoxicity in a Novel Anthracycline Analogue, 4’-Amino-3’-Hydroxy-Doxorubicin.” Cancer Chemotherapy and Pharmacology, vol. 29, no. 4, 1992, pp. 261–65. EBSCOhost, https://doi.org/10.1007/BF00685942.

APA

Danesi, R., Bernardini, N., Agen, C., Costa, M., Zaccaro, L., Pieracci, D., Malvaldi, G., & Del Tacca, M. (1992). Reduced cardiotoxicity and increased cytotoxicity in a novel anthracycline analogue, 4’-amino-3’-hydroxy-doxorubicin. Cancer Chemotherapy and Pharmacology, 29(4), 261–265. https://doi.org/10.1007/BF00685942

Chicago

Danesi, R, N Bernardini, C Agen, M Costa, L Zaccaro, D Pieracci, G Malvaldi, and M Del Tacca. 1992. “Reduced Cardiotoxicity and Increased Cytotoxicity in a Novel Anthracycline Analogue, 4’-Amino-3’-Hydroxy-Doxorubicin.” Cancer Chemotherapy and Pharmacology 29 (4): 261–65. doi:10.1007/BF00685942.